It's funny that I mention this because I initially started trying to buy Citi shares when they were at a dollar, but because of my sporadic transfers to my online brokerage account they were back to $3.10 before my money was available and I jumped in. I still like my position but wish that I didn't know multiplication and division because they will haunt my investing nightmares for years to come (one week cost me roughly 300% of return, but who wants to triple their money anyway?). Regardless, I thoroughly enjoyed watching the stock reverse-Plinko up to its nifty close at $4.48 today, but I worry about tomorrow. I think that the 5.6% advantage that Citi had over the KBW index today is earned, but I find myself cringing at the idea of the stock being brow-beaten back to sub-$4 levels simply because of speculation that "they're not out of the woods yet." Granted, they aren't, but management has their compasses out and are headed for the clearing like they were Bear Grylls. A few recent successes (converting preferred shares to common; offloading some burdensome assets) have been big but overhype may continue to set back any actual sense of recovery. Boom or bust is bad for Citi because 8.5% gains won't save them from short-term 8.5% losses, and my tiny portfolio would prefer steady, slow growth from C.
Turns out that I was right on Terremark, at least for now. I'm not sure what spurred the 3% increase today, but after perusing their quarterly report from roughly a week ago I like this pick even more. Too bad I still haven't completely figured out my CAPS picks yet because I would've liked the little boost I would've received. Oh well, you win some and lose some.
Lastly, I just added Geron to my CAPS picks on a conservative three year expecation. I say conservative because I really don't think it will take that long, but sometimes I listen to people who I assume know more than I do but really don't. I'll be brief here to avoid an irrelevant diatribe; Geron was blessed with the FDA's first embryonic stem-cell trial. This isn't something (I pray) that they would hand out lightly, especially since they have to be aware of the very large public concern regarding stem cell therapies of any kind. My brain tells me that everybody here is preceeding with caution which is why I say cut loose a little, a la Mr. Buffett. But then again I like the gamble...